HUNTINGTON NATIONAL BANK - PERNIX THERAPEUTICS HLDGS IN ownership

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q1 2016$14,0000.0%1,2630.0%0.00%
Q1 2015$14,000
-17.6%
1,263
-29.3%
0.00%
Q4 2014$17,0001,7870.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 1,134,578$10,654,0007.22%
Consonance Capital Management LP 3,427,789$32,187,0004.15%
ACUTA CAPITAL PARTNERS, LLC 604,075$5,672,0003.83%
KOPP INVESTMENT ADVISORS LLC 758,233$7,119,0003.42%
Aisling Capital LLC 2,010,000$18,874,0002.86%
Broadfin Capital, LLC 6,100,000$57,280,0002.49%
THOMPSON DAVIS & CO., INC. 154,760$1,453,0001.68%
RUDMAN ERROL M 300,000$2,817,0001.14%
WALL STREET ASSOCIATES 1,259,500$11,827,0001.13%
Timpani Capital Management LLC 291,377$2,736,0001.08%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders